Study for the clinical characteristics and digestive system damage of novel coronavirus pneumonia (COVID-19)

Study for the clinical characteristics and digestive system damage of novel coronavirus pneumonia COVID-19

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000030519

Enrollment

Unknown

Registered

2020-03-05

Start date

2020-03-06

Completion date

Unknown

Last updated

2020-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Case series:Nil

Eligibility

Sex/Gender

All

Age

18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Pharyngeal swabs and / or anal swab specimens are positive for new coronavirus nucleic acids, or viral gene sequencing is highly homologous to known new coronaviruses; 2. Males and females aged 18 to 85 years; 3. Participants should fully understand the purpose, nature, methods and possible complications of the trial, volunteer to participate in this study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients who have contraindications to specimen collection, such as: coagulopathy, rectal tumors, anal canal disease, severe cardiopulmonary dysfunction, etc .; 2. Patients with mental illness cannot cooperate with sampling; 3. The patient did not agree to participate in the study.

Design outcomes

Primary

Measure	Time frame
RNA of Coronavirus;	—

Countries

China

Contacts

Public ContactChuo Li

Guangzhou Eighth People's Hospital

gz8hlc@126.com+86 15989096626

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026